| 1 |
Huan R, Yue J, Lan J, Wang J, Cheng Y, Zhang J, Tan Y. Hypocretin-1 suppresses malignant progression of glioblastoma cells through Notch1 signaling pathway. Brain Res Bull 2023;196:46-58. [PMID: 36925051 DOI: 10.1016/j.brainresbull.2023.03.006] [Reference Citation Analysis]
|
| 2 |
Tehrani S, Yadegarynia D, Keyvanfar A. A Case-report of Concurrent Pulmonary and Cerebral Lesions in a Patient with Polymyositis: Invasive Aspergillosis or Astrocytoma? Jundishapur J Microbiol 2023;15. [DOI: 10.5812/jjm-132821] [Reference Citation Analysis]
|
| 3 |
Zhou Y, Xiao X, Peng C, Song D, Ouyang F, Wang L. Progesterone induces glioblastoma cell apoptosis by coactivating extrinsic and intrinsic apoptotic pathways. Mol Cell Toxicol 2023. [DOI: 10.1007/s13273-022-00327-w] [Reference Citation Analysis]
|
| 4 |
Wang J, Liu Y, Zhang A, Yu W, Lei Q, Xiao B, Luo Z. Investigational Microbiological Therapy for Glioma. Cancers (Basel) 2022;14. [PMID: 36497459 DOI: 10.3390/cancers14235977] [Reference Citation Analysis]
|
| 5 |
Shao C, Tang H, Wang X, He J, Wang P, Wu N. Body mass index and glioma risk: A prospective multicenter study. Front Endocrinol 2022;13:933921. [DOI: 10.3389/fendo.2022.933921] [Reference Citation Analysis]
|
| 6 |
Hirtz A, Lebourdais N, Thomassin M, Rech F, Dumond H, Dubois-pot-schneider H. Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. Cancers 2022;14:4114. [DOI: 10.3390/cancers14174114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Shao C, Tang H, Wang X, He J, Wang P, Wu N. Oral Contraceptive and Glioma Risk: A Prospective Cohort Study and Meta-Analysis. Front Public Health 2022;10:878233. [DOI: 10.3389/fpubh.2022.878233] [Reference Citation Analysis]
|
| 8 |
Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol 2022:S1044-579X(22)00155-9. [PMID: 35779712 DOI: 10.1016/j.semcancer.2022.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Kurowska N, Strzalka-Mrozik B, Madej M, Pająk K, Kruszniewska-Rajs C, Kaspera W, Gola JM. Differences in the Expression Patterns of TGFβ Isoforms and Associated Genes in Astrocytic Brain Tumors. Cancers (Basel) 2022;14. [PMID: 35454784 DOI: 10.3390/cancers14081876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Zhao L, Ma Y, Shu Q, Sun H, Lu J, Gong P, Meng F, Wan F. AHR agonist ITE boosted PD1 antibody’s effects by inhibiting myeloid-derived cells suppressive cells in an orthotopic mouse glioma model.. [DOI: 10.1101/2022.03.14.484219] [Reference Citation Analysis]
|
| 11 |
Li C, Liu J, Yang W, Chen C, Wu B. The relationship among integrin alpha 7, CD133 and Nestin as well as their correlation with clinicopathological features and prognosis in astrocytoma patients. Clinical Neurology and Neurosurgery 2022. [DOI: 10.1016/j.clineuro.2022.107198] [Reference Citation Analysis]
|
| 12 |
Sarbu M, Ica R, Zamfir AD. Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry. Int J Mol Sci 2022;23:693. [PMID: 35054879 DOI: 10.3390/ijms23020693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Feng Y, Lim S, Lin H, Wang S, Hsu S, Kao T, Ko C, Hsu T. Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression. The Journal of Steroid Biochemistry and Molecular Biology 2022. [DOI: 10.1016/j.jsbmb.2022.106067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Wu YY, Xu YM, Lau ATY. Anti-Cancer and Medicinal Potentials of Moringa Isothiocyanate. Molecules 2021;26:7512. [PMID: 34946594 DOI: 10.3390/molecules26247512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Hirtz A, Lebourdais N, Rech F, Bailly Y, Vaginay A, Smaïl-Tabbone M, Dubois-Pot-Schneider H, Dumond H. GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation. Cells 2021;10:3438. [PMID: 34943948 DOI: 10.3390/cells10123438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Lim TX, Ahamed M, Reutens DC. The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma. Drug Discov Today 2021:S1359-6446(21)00427-X. [PMID: 34624509 DOI: 10.1016/j.drudis.2021.09.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Lin HY, Liao KH, Ko CY, Chen GY, Hsu SP, Hung CY, Hsu TI. 17β-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma. Free Radic Biol Med 2021;172:430-40. [PMID: 34186205 DOI: 10.1016/j.freeradbiomed.2021.06.028] [Reference Citation Analysis]
|
| 18 |
Hernando-Pérez E, Pérez-Riesgo E, Cepeda S, Arrese I, Sarabia R, Villalobos C, Núñez L. Differential Ca2+ responses and store operated Ca2+ entry in primary cells from human brain tumors. Biochim Biophys Acta Mol Cell Res 2021;1868:119060. [PMID: 33992673 DOI: 10.1016/j.bbamcr.2021.119060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
